The loss of p27 protein has an independent prognostic significance in gastric cancer

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4215-4220

  Kwon, O Joong ^a   Kang, Han Sung ^a   Suh, Jun Suk ^a   Chang, Mee Soo ^a   Jang, Ja June ^b   Chung, Jung Kee ^a  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Cyclin E; Gastric cancer; p27; Prognostic factor

Indexed keywords

CYCLIN E; PARAFFIN; PROTEIN P27;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; STOMACH CANCER;

EID: 0032779856     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kim JP, Kwon OJ, Oh ST, Yang HK: Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 216: 269-78, 1992.
2. Kim JP, Kim YW, Yang HK, Noh DY: Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg 18: 872-877, 1994.
3. Dulic V, Lees E, Reed SI: Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958-1961, 1992.
4. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Roberts JM: Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66: 1217-1228, 1996.
5. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR, Roberts JM: Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570-573, 1994.
6. Coats S, Flanagan WM, Nourse J, Roberts JM: Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272: 877-880, 1996.
7. Clurman BE, Roberts JM: Cell cycle and cancer. J Natl Cancer Inst 87: 1499-1501, 1995.
8. Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP: p27/Kip1 mutation found in breast cancer. Cancer Res 56: 2400-2404, 1996.
9. Leach FS, Elledge SJ, Sherr CJ, Willson JK, Markowitz S, Kanzler KW, Vogelstein B: Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53: 1986-1989, 1993.
10. Gerdes J, Becker MH, Key G, Cafforetti G: Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 168: 85-86, 1992.
11. Catzavelos C, Bhattacharya N, Ung Yee, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Fransen E, Protchard KI, Slingerland JM: Decreased level of the cell-cycle inhibitor p27 protein: prognostic implications in primary breast cancer. Nat Med 3: 227-230, 1997.
12. Lees E: Cyclin dependent kinase regulation. Curr Opin Cell Biol 6: 877-882, 1994.
13. Hartwell LH, Kastan MB. Cell Cycle Control and Cancer. Science 266: 821-828, 1994.
14. Hengst L, Reed SI: Translational control of p27Kip1 accumulation during the cell cycle. Science 271: 1861-1864, 1996.
15. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269(5224): 682-685, 1995.
16. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M: Increased proteosome-dependent degradation of the cyclin- dependent kinase inhibitor p27 in aggressive colorectal carcinoma. Nat Med 3: 231-234, 1997.
17. Motokura T, Arnold A: Cyclins and oncogenesis. Biochem Biophys Acta 1155: 63-78, 1993.
18. Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T, Tahara E: Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 86: 617-621, 1995.
19. Keyomarsi K, Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112, 1993.
20. Keyomarsi K, Conte Jr D, Toyofuku W, Fox MP: Deregulation of cyclin E in breast cancer. Oncogene 11: 941, 1995.
21. Kitahara K, Yasui W, Kuniyasu H, Yokozaki H, Akama Y, Yunotani S, Hisatsugu T, Tahara E: Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas. Int J Cancer 62: 25-28, 1995.
22. Scuderi R, Palucka KA, Pokrovskaja K, Bjorkholm M, Wiman KG, Pisa P. Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage. Blood 87: 3360-3367, 1996.
23. Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM: Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev 10: 1979-1990, 1996.
24. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852, 1994.
25. St Croix B, Florenes VA, Rak JW, Flanagan M, Bhattacharya N, Slingerland JM, Kerbel RS: Impact of the cyclin dependent kinase inhibitor p27 kip1 on adhesion-dependent resistance of tumor cells to anticancer agents. Nat Med 2: 1204-1210, 1996.
26. Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, Assoian RK: Adhesion dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-CDK2, and phosphorylation of the retinoblastoma protein. J Cell Biol 133: 391-403, 1996.
27. Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, Lavin P, Draetta G, Pagano M, Loda M: The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,1b) invasive breast carcinoma; Cancer Res 57: 1259-1263, 1997.
28. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB: Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385, 1994.
29. Dou Q-P, Pardee AB, Keyomarsi K: Cyclin E - a better prognostic marker for. breast cancer than cyclin D? Nat Med 2: 254, 1996.
30. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM: Expression of cell-cycle regulators p27 Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222-225, 1997.
31. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM: A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 76: 1302-1312, 1995.
32. Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T: Lymph node metastases of gastric cancer: general pattern in 1931 patients. Ann Surg 210: 596-502, 1989.
33. Maehara Y, Okuyama T, Moriguchi S, Orita H, Kusumoto H, Korenaga D, Sugimachi K: Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer 70: 392-395, 1992.
34. Miwa K: Evaluation of TNM classification of stomach cancer and proposal for its rational stage-grouping. Jpn J Clin Oncol 14: 385-410, 1984.